Choo Chee Kong's Form 4 filing
CytoMed Therapeutics Ltd (GDTC) · filed Jul 24, 2026
- Accession no.
- 0001493152-26-034516
- Filed
- Jul 24, 2026, 12:33 PM ET
- Trade date
- Jul 14-20, 2026
- Filing delay
- 10 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $300.0K. It was filed 10 days after the trade, past the 2-business-day deadline.
This filing was later replaced by the amendment 0001493152-26-034654 (Jul 24, 2026). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Choo Chee KongCIK 0001970632 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 14, 2026 | ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | PPurchaseDisposed | −100,000 | $1.50 | −$150,000 | 530,324 | Direct | |
| Jul 20, 2026 | ORDINARY SHARES OF CYTOMED THERAPEUTICS LIMITED | PPurchaseDisposed | −100,000 | $1.50 | −$150,000 | 630,324 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.